Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

A Glimmer of Hope for Johnson & Johnson Despite Lawsuit Concerns and FDA Scrutiny
Motley Fool
Thursday, June 7, 2012 - 3:13pm
tags:
JNJ, FDA
Grassley To SEC: Probe Vertex Stock Sales
Pharmalot
Thursday, June 7, 2012 - 2:18pm
tags:
Charles Grassley, SEC, Vertex Pharmaceuticals
GenVec's cattle vaccine gets conditional approval, shares up
Reuters
Thursday, June 7, 2012 - 2:05pm
tags:
GenVec, animal health
First Tuberculosis Drug In 40 Years Has Otsuka Cautious
Bloomberg
Thursday, June 7, 2012 - 11:03am
tags:
tuberculosis, Otsuka, delamanid
Provenge Has A Bigger Market Than You Think
Seeking Alpha
Thursday, June 7, 2012 - 10:59am
tags:
Provenge, prostate cancer, Dendreon
Glaxo, Xenoport's Drug Approved to Treat Shingles Pain
Minyanville
Thursday, June 7, 2012 - 10:56am
tags:
GSK, XenoPort, shingles, Horizant
Pfizer on track to create standalone Animal Health by July 2013
Yahoo/Fly on the Wall
Thursday, June 7, 2012 - 10:55am
tags:
animal health, reorganization, Pfizer
Roche Drug Reduces Skin Growths In Gene-Mutation Patients
Bloomberg
Wednesday, June 6, 2012 - 5:30pm
tags:
skin cancer, Roche, Erivedge
Eli Lilly CEO Says No Big Deals
WSJ Online
Wednesday, June 6, 2012 - 5:29pm
tags:
John Lechleiter, Pharma CEOs, Eli Lilly, M&A
Do Sunshine Disclosure Laws Make A Difference?
Pharmalot
Wednesday, June 6, 2012 - 3:57pm
tags:
Physician Payment Sunshine Act, physicial payments
House would cut $16 million from FDA funding
Fierce Pharma
Wednesday, June 6, 2012 - 3:56pm
tags:
FDA, congress
Questcor Stock Rebounds On Monthly Acthar Data
Investors.com
Wednesday, June 6, 2012 - 3:55pm
tags:
Questcor, Acthar
BioCryst jumps ahead of study presentation
Marketwatch
Wednesday, June 6, 2012 - 3:33pm
tags:
Biocryst, BCX4208, gout
Abbott, Roche Issue Dueling Arthritis Drug Reports
Investors.com
Wednesday, June 6, 2012 - 3:32pm
tags:
Roche, rheumatoid arthritis, Abbott Laboratories, Humira, Actemra
Biotech All Stars Buy Castoff Experimental Merck Cancer Drug
Forbes
Wednesday, June 6, 2012 - 3:30pm
tags:
Merck, Tesaro, niraparib, breast cancer, ovarian cancer
Novartis: Positive Phase-3 Results
Yahoo/Zacks.com
Wednesday, June 6, 2012 - 12:54pm
tags:
Novartis, Illaris, systematic juvenile idiopathic arthritis
ViroPharma Initiates Phase II Study
Yahoo/Zacks.com
Wednesday, June 6, 2012 - 10:56am
tags:
ViroPharma, maribavir, CMV
US FDA rejects Merck/Ariad sarcoma drug
Reuters
Wednesday, June 6, 2012 - 10:53am
tags:
FDA, Merck, Ariad Pharmaceuticals, sarcoma, Taltorvic
Can Dendreon Cure Its 52-Week-Low Woes?
Motley Fool
Wednesday, June 6, 2012 - 10:51am
tags:
Dendreon, Provenge
Human Genome Sciences And GlaxoSmithKline: When A Marriage Goes Sour
Seeking Alpha
Wednesday, June 6, 2012 - 10:47am
tags:
GSK, Human Genome Sciences, M&A

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.